Financials
- Market Capitalization 570.47 M
- Employee 2 700
- Founded 1991
- CEO Paul J. DiazPaul J. Diaz
- Website www.myriad.com
- Headquarter Delaware, United States
- FIGI BBG000D9H9F1
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2695 | CSTL Castle Biosciences, Inc. - Common stock | 23.12 USD | +0.61% | -1.41% | +11.64% | -6.07% | 701.23 M USD | ||
| 2824 | FLGT Fulgent Genetics, Inc. - Common Stock | 20.46 USD | +0.20% | -1.45% | +12.42% | -13.42% | 581.08 M USD | ||
| 3184 | PRE Prenetics Global Limited - Class A Ordinary Share | 21.24 USD | +13.70% | +27.95% | +1.14% | +154.37% | 358.41 M USD | ||
| 3254 | LAB Standard BioTools Inc. - Common Stock | 0.84 USD | -1.18% | -6.67% | 0.00% | -30.58% | 327.66 M USD |
Frequently asked questions about Myriad Genetics, Inc. - Common Stock
What is the Myriad Genetics, Inc. - Common Stock stock price today?
The current price of Myriad Genetics, Inc. - Common Stock (MYGN) is 6.04. Over the past 24 hours, the stock has changed by +3.07%. Follow the MYGN chart for real-time price dynamics.
What is the stock ticker of Myriad Genetics, Inc. - Common Stock?
Myriad Genetics, Inc. - Common Stock trades under the ticker MYGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Myriad Genetics, Inc. - Common Stock stock going up?
MYGN has changed by +3.96% over the last week, +40.14% over the last month, and -26.96% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Myriad Genetics, Inc. - Common Stock net income for the last quarter?
Myriad Genetics, Inc. - Common Stock reported net income of -34.1 M for the last quarter. The previous quarter showed -7.9 M, which means net income changed by -331.65%.
How many employees does Myriad Genetics, Inc. - Common Stock have?
As of the latest available data, Myriad Genetics, Inc. - Common Stock has 2 700 employees. Workforce size can provide additional context about the company's scale and operations.
What is Myriad Genetics, Inc. - Common Stock EBITDA?
Myriad Genetics, Inc. - Common Stock EBITDA is -18.1 M, and its EBITDA margin is -9.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Myriad Genetics, Inc. - Common Stock stock?
You can buy Myriad Genetics, Inc. - Common Stock (MYGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Myriad Genetics, Inc. - Common Stock stock?
Investing in Myriad Genetics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MYGN chart and related analysis on metatrader.com as part of your research.